How can we identify modifiable risk factors and new therapeutic targets in polymyalgia rheumatica?

In this episode, recorded live at BSR25, Prof Ernest Choy and Dr Steven Zhao discuss Steven's genome-wide meta-analysis and Mendelian randomisation study. They cover the key findings, which include some novel loci and potential therapeutic targets for PMR, as well as the hallmarks of a good Mendelian randomisation study. 

Further reading:

  1. Read Steven's full study in Rheumatology


Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. 

Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice. 

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör British Society for Rheumatology. Innehållet i podden är skapat av British Society for Rheumatology och inte av, eller tillsammans med, Poddtoppen.